Lotus Technology Management’s Hims & Hers Health HIMS Stock Holding History

Lotus Technology Management’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-27,454	Closed	-$891K	–	96
2025 Q4	$891K	Buy	+27,454	New	+$1.18M	0.5%	68

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Defiance ETFs New York $7.37B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Lotus Technology Management's HIMS Position: Q1 2026 in Review

Lotus Technology Management sold out of Hims & Hers Health (HIMS) in Q1 2026, closing a stake of 27,454 shares — an estimated $891K sold.

Lotus Technology Management first reported a position in HIMS in Q4 2025 and held it in 1 quarter. The position peaked at $891K in Q4 2025. 435 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

Lotus Technology Management reported no remaining Hims & Hers Health position as of Q1 2026 after selling out during the quarter.
Lotus Technology Management sold 27,454 Hims & Hers Health shares in Q1 2026, an estimated $891K.
Lotus Technology Management first reported a position in Hims & Hers Health in Q4 2025 and held it in 1 quarter.
Lotus Technology Management's Hims & Hers Health position peaked at $891K in Q4 2025.
435 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on Lotus Technology Management's 13F filing for Q1 2026, filed 15 May 2026.